Andreas P. Freidig

2.1k citations

47 papers · 1.4k indexed · h-index 23

Chemical Health and Safety top 5%
Health, Toxicology and Mutagenesis top 5%
- Environmental Toxicology and Ecotoxicology 6
- Effects and risks of endocrine disrupting chemicals 6
Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 8
Pollution top 5%
Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment 8
Computational Theory and Mathematics
- Computational Drug Discovery Methods 6
Oncology
- Drug Transport and Resistance Mechanisms 5
Molecular Biology
- Metabolomics and Mass Spectrometry Studies 3
Spectroscopy
- Analytical Chemistry and Chromatography 3

Co-authors: Joop L. M. Hermens Wouter H. J. Vaes Peter J. van Bladeren Miriam Verwei Henk J. M. Verhaar Ivonne M.C.M. Rietjens Johannes J.M. van de Sandt Ben van Ommen
Cited by: Chemical Health and Safety Health, Toxicology and Mutagenesis Pharmacology
Journals: Circulation (1 paper)Environmental Science & Technology (2 papers)Blood (1 paper)
Partner nations: Netherlands United States Switzerland

In The Last Decade

Andreas P. Freidig

47 papers receiving 1.4k citations

Peers

Countries citing papers authored by Andreas P. Freidig

Since Specialization

Citations

This map shows the geographic impact of Andreas P. Freidig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas P. Freidig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas P. Freidig more than expected).

Fields of papers citing papers by Andreas P. Freidig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas P. Freidig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas P. Freidig. The network helps show where Andreas P. Freidig may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Andreas P. Freidig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas P. Freidig Line = papers co-authored together Andreas P. Freidig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Dietary Medium Chain Fatty Acid Supplementation Leads to Reduced VLDL Lipolysis and Uptake Rates in Comparison to Linoleic Acid Supplementation PLoS ONE ·Daniël B. van Schalkwijk,Wilrike J. Pasman,H. Hendriks,Elwin Verheij,Carina M. Rubingh,Kees van Bochove,Wouter H. J. Vaes,Martin Adiels,Andreas P. Freidig,Albert A. de Graaf	2014	30
2	Abstract 16900: Gene Therapy With Alipogene Tiparvovec Results in Enhanced Post-Prandial Clearance of Low Density Chylomicrons in LPLD Patients Circulation ·André C. Carpentier,Frédérique Frisch,Sébastien M. Labbé,Julie Méthot,Claude Gagné,S. Déry,Karine Tremblay,J. de Wal,Jaap Twisk,Andreas P. Freidig,Diane Brisson,Daniel Gaudet	2010	2
3	Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency Atherosclerosis Supplements ·Daniel Gaudet,J. de Wal,Karine Tremblay,S. Déry,Sander van Deventer,Andreas P. Freidig,Diane Brisson,Julie Méthot	2010	86
4	Developing computational model-based diagnostics to analyse clinical chemistry data Briefings in Bioinformatics ·Daniël B. van Schalkwijk,Kees van Bochove,Ben van Ommen,Andreas P. Freidig,Eugene P. van Someren,J. van der Greef,Albert A. de Graaf	2010	6
5	New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes Regulatory Toxicology and Pharmacology ·Harrie Buist,Johan A. van Burgsteden,Andreas P. Freidig,Wilfred Maas,Johannes J.M. van de Sandt	2010	28
6	Improved cholesterol phenotype analysis by a model relating lipoprotein life cycle processes to particle size Journal of Lipid Research ·Daniël B. van Schalkwijk,Albert A. de Graaf,Ben van Ommen,Kees van Bochove,Patrick C.N. Rensen,Louis M. Havekes,Niek C.A. van de Pas,Huub C. J. Hoefsloot,J. van der Greef,Andreas P. Freidig	2009	20
7	Nutritional Systems Biology Modeling: From Molecular Mechanisms to Physiology PLoS Computational Biology ·Albert A. de Graaf,Andreas P. Freidig,Baukje de Roos,Neema Jamshidi,Matthias Heinemann,J.A.C. Rullmann,Kevin D. Hall,Martin Adiels,Ben van Ommen	2009	114
8	A network biology model of micronutrient related health British Journal Of Nutrition ·Ben van Ommen,Susan J. Fairweather‐Tait,Andreas P. Freidig,A.F.M. Kardinaal,Augustin Scalbert,Suzan Wopereis	2008	39
9	Quercetin increases the bioavailability of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats Food and Chemical Toxicology ·Maaike E. Schutte,G.M. Alink,Andreas P. Freidig,Bert Spenkelink,Judith Vaessen,Johannes J.M. van de Sandt,John P. Groten,Ivonne M.C.M. Rietjens	2008	6
10	Clearance and clearance inhibition of the HIV-1 protease inhibitors ritonavir and saquinavir in sandwich-cultured rat hepatocytes and rat microsomes Toxicology in Vitro ·Nicoline Treijtel,J.C.H. van Eijkeren,Sandra M. Nijmeijer,I.C.J. de Greef-van der Sandt,Andreas P. Freidig	2008	5
11	The Use of Metabolising Systems for In Vitro Testing of Endocrine Disruptors Current Drug Metabolism ·Miriam N. Jacobs,Wim Janssens,Ulrike Bernauer,Esther Brandon,Sandra Coecke,Robert D. Combes,Philip D. Edwards,Andreas P. Freidig,Alexius Freyberger,Richard C. Kolanczyk,C. Mc Ardle,Ovanes Mekenyan,P. Schmieder,Timothy Schrader,Masahiro Takeyoshi,Bart van der Burg	2008	43
12	A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat Toxicology and Applied Pharmacology ·Ans Punt,Andreas P. Freidig,Thierry Delatour,Gabriele Scholz,Marelle G. Boersma,Benoı̂t Schilter,Peter J. van Bladeren,Ivonne M.C.M. Rietjens	2008	71
13	Development of a QSAR for worst case estimates of acute toxicity of chemically reactive compounds Toxicology Letters ·Andreas P. Freidig,Susan Dekkers,Miriam Verwei,Elton Zvinavashe,Jos Bessems,Johannes J.M. van de Sandt	2007	24
14	Predicted Serum Folate Concentrations Based on In Vitro Studies and Kinetic Modeling are Consistent with Measured Folate Concentrations in Humans Journal of Nutrition ·Miriam Verwei,Andreas P. Freidig,R. Havenaar,John P. Groten	2006	42
15	Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling Toxicology Letters ·Miriam Verwei,Johan A. van Burgsteden,Cyrille Krul,Johannes J.M. van de Sandt,Andreas P. Freidig	2006	73
16	An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers Toxicology and Applied Pharmacology ·Maaike E. Schutte,Andreas P. Freidig,Johannes J.M. van de Sandt,G.M. Alink,Ivonne M.C.M. Rietjens,John P. Groten	2006	19
17	Toxicology of chemical mixtures: a challenging quest along empirical sciences Environmental Toxicology and Pharmacology ·John P. Groten,Wilbert H. M. Heijne,Rob Stierum,Andreas P. Freidig,V.J. Feron	2004	18
18	MODELING THE IN VITRO INTRINSIC CLEARANCE OF THE SLOWLY METABOLIZED COMPOUND TOLBUTAMIDE DETERMINED IN SANDWICH-CULTURED RAT HEPATOCYTES Drug Metabolism and Disposition ·Nicoline Treijtel,Arjan Barendregt,Andreas P. Freidig,Bas J. Blaauboer,J.C.H. van Eijkeren	2004	27
19	Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling Chemico-Biological Interactions ·Jan J.P. Bogaards,Andreas P. Freidig,Peter J. van Bladeren	2001	14
20	1-Octanol/water distribution coefficient of oxolinic acid: influence of pH and its relation to the interaction with dissolved organic carbon Chemosphere ·Hans‐Christian Holten Lützhøft,Wouter H. J. Vaes,Andreas P. Freidig,Bent Halling‐Sørensen,Joop L. M. Hermens	2000	20

About Andreas P. Freidig

Andreas P. Freidig is a scholar working on Chemical Health and Safety, Health, Toxicology and Mutagenesis and Pharmacology, having authored 47 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Carcinogens and Genotoxicity Assessment (8 papers), Environmental Toxicology and Ecotoxicology (6 papers), Effects and risks of endocrine disrupting chemicals (6 papers), Computational Drug Discovery Methods (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Chemical Health and Safety (17 citations), Health, Toxicology and Mutagenesis (340 citations) and Pharmacology (141 citations). Andreas P. Freidig has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Joop L. M. Hermens, Wouter H. J. Vaes, Peter J. van Bladeren, Miriam Verwei, Henk J. M. Verhaar, Ivonne M.C.M. Rietjens, Johannes J.M. van de Sandt, Ben van Ommen, John P. Groten and Hans‐Christian Holten Lützhøft. Their work appears in journals such as Circulation, Environmental Science & Technology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact